Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem
Jeffery J. Auletta, Brenda M. Sandmaier, Erica Jensen, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 12, pp. 802-809
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
Jeffery J. Auletta, Jianqun Kou, Min Chen, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 6, pp. 346.e1-346.e10
Open Access | Times Cited: 43
Overcoming Barriers to Referral for Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
Marc Hoffmann, Bradley D. Hunter, Patrick Cobb, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 7, pp. 440-448
Open Access | Times Cited: 36
Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation
Warren Fingrut, Eric Davis, Anne Archer, et al.
Blood Advances (2024) Vol. 8, Iss. 11, pp. 2753-2764
Open Access | Times Cited: 8
Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities
Nandita Khera, Sikander Ailawadhi, Ruta Brazauskas, et al.
Blood Advances (2024) Vol. 8, Iss. 13, pp. 3497-3506
Open Access | Times Cited: 7
Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity
Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson, et al.
Blood (2024) Vol. 143, Iss. 26, pp. 2722-2734
Open Access | Times Cited: 6
Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies
Sarah Nikiforow, Matthew J. Frigault, Noelle V. Frey, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 4, pp. 228-239
Open Access | Times Cited: 14
The Rules of T-cell Engagement: Current State of CAR T-cells and Bispecific Antibodies in B-cell Lymphomas
J. Erika Haydu, Jeremy S. Abramson
Blood Advances (2024) Vol. 8, Iss. 17, pp. 4700-4710
Open Access | Times Cited: 5
Assessing Medicaid Coverage for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy: A Project from the American Society for Transplantation and Cellular Therapy and the National Marrow Donor Program ACCESS Initiative
Jeffery J. Auletta, Nandita Khera, Patrick DeMartino, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 11, pp. 713-720
Closed Access | Times Cited: 12
Racial, Ethnic and Socioeconomic Diversity and Outcomes of Patients with Graft-versus-Host Disease: A CIBMTR Analysis
Nosha Farhadfar, Nahid Rashid, Karen Chen, et al.
Blood Advances (2024) Vol. 8, Iss. 18, pp. 4963-4976
Open Access | Times Cited: 3
Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia
Daniel J. Olivieri, Megan Othus, Corentin Orvain, et al.
Leukemia (2024) Vol. 38, Iss. 4, pp. 865-876
Closed Access | Times Cited: 2
Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease Care
Andrew D. Trunk, Michelle Guo, Laura Budvytyte, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 2
Applying Implementation Science in the Field of Transplant and Cellular Therapy
Anna M. DeSalvo, Stephen R. Spellman, Jennifer A. Sees, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 9, pp. 864-875
Closed Access | Times Cited: 2
Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation
Karen K. Ballen, Tao Wang, Naya He, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 10, pp. 1027.e1-1027.e14
Closed Access | Times Cited: 2
Association between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate allografts in adult BMT recipients
Warren Fingrut, Stephanie Chinapen, Jessica Flynn, et al.
Blood Advances (2023) Vol. 7, Iss. 15, pp. 3834-3837
Open Access | Times Cited: 6
Reducing barriers of access and care related to hematopoietic cell transplantation and cellular therapy: The mission-driven role of the national marrow donor program
Rafeek A. Yusuf, Jaime M. Preussler, Christa L. Meyer, et al.
Best Practice & Research Clinical Haematology (2023) Vol. 36, Iss. 2, pp. 101480-101480
Closed Access | Times Cited: 6
Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop
Jeffery J. Auletta, Jennifer Holter‐Chakrabarty, Tania Jain, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 12, pp. 739-746
Open Access | Times Cited: 5
Access offsets poverty in quest for CAR T cells
Rayne H. Rouce, Eneida R. Nemecek
Blood (2023) Vol. 141, Iss. 6, pp. 558-560
Open Access | Times Cited: 4
Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies
Nandita Khera, Marie Louise Edwards, Yan Song, et al.
Advances in Therapy (2024) Vol. 41, Iss. 4, pp. 1637-1651
Open Access | Times Cited: 1
Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop
Jeffery J. Auletta, Jennifer Holter‐Chakrabarty, Pashna N. Munshi, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 12, pp. 1124-1138
Closed Access | Times Cited: 1
How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?
Mark Juckett, Christopher E. Dandoy, Zachariah DeFilipp, et al.
Blood Reviews (2023) Vol. 60, pp. 101079-101079
Open Access | Times Cited: 3
Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based Study
Naseem Esteghamat, Ann Brunson, Aaron S. Rosenberg, et al.
Clinical Lymphoma Myeloma & Leukemia (2023) Vol. 24, Iss. 4, pp. e119-e129
Closed Access | Times Cited: 3
Identifying and Preventing Disparities in Access to Curative Therapy for SCD
Staci D. Arnold
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 1, pp. 9-10
Open Access
The Evolution of Hematopoietic Stem Cell Transplantation to Overcome Access Disparities: The Role of NMDP
Steven M. Devine
Cells (2024) Vol. 13, Iss. 11, pp. 933-933
Open Access
Disparities in access to hematopoietic cell transplant persist at a transplant center
Jamie Shoag, Seth J. Rotz, Rabi Hanna, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 9, pp. 1258-1264
Open Access
Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study
Christa L. Meyer, Theresa H.M. Keegan, Ann Brunson, et al.
Haematologica (2024)
Open Access
Page 1 - Next Page

Scroll to top